Table: begin end state 1 46 cytoplasmic 47 66 transmembrane 67 71 non-cytoplasmic 72 96 transmembrane 97 107 cytoplasmic 108 127 transmembrane 128 131 non-cytoplasmic 132 160 transmembrane 161 172 cytoplasmic 173 195 transmembrane 196 206 non-cytoplasmic 207 228 transmembrane 229 258 cytoplasmic 259 281 transmembrane 282 295 non-cytoplasmic 296 318 transmembrane 319 326 cytoplasmic 327 345 transmembrane 346 353 non-cytoplasmic 354 374 transmembrane 375 386 cytoplasmic 387 409 transmembrane 410 411 non-cytoplasmic 412 413 transmembrane 414 414 non-cytoplasmic 415 435 transmembrane 436 446 cytoplasmic
Input: >CCNA_01852 MASELAIPKSSGLERDARRMHADDKGVRPGEIALGVVIGRTSEFFDFFVYAIASVLVFPQ LVFPFVDRLTGVMLAFGLFALAFIARPFGSVIFGAIDQRYGRGVKLTIALFLLGGSTAVI SMLPSFAAVGPIAIWALAACRIGQGLALAGAWDGMASLLALNAPENKRGWYAMIPQLGAP FGFMLASGLFAYFVATLAPADFLDWGWRYPFFAAFAINVVALFARLRIVATEEFGALFEK RELRPTRVASLLRAEGGNVLIGAFAPLATFAMFHLVTVFPLSWVVLHGDAQQALNFLRIE LFGALVGVGGILASGWIADRITRQNQLALSALLIGAFSLLAPRLLDGGATGQTAYVVIGF AILGLSFGQAAGAVSSGFSKRYRYTGAALTSDLSWLIGAGFAPLAALGLASLWGLPAIGL YLASGALATLLALTIDRTRRRRQAHC
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server